FDA Inspection 1092014 — Custom Compounding Center

Custom Compounding Center — FEI 3002401385

The FDA completed an inspection of Custom Compounding Center on June 4, 2019 in Little Rock, AR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 4, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Little Rock, AR (United States)

Citations

IDCFRDescription
18938FDCA 501(a)(2)(A)Hazardous drugs, prevention of cross-contamination